| Document |
Document Title |
|
WO/2012/060396 |
The purpose of the present invention is to provide a novel trans-2-decenoic acid derivative and a pharmaceutically acceptable salt thereof, and a medicament containing the compound described above as an active component and having a neur...
|
|
WO/2012/041013 |
The present disclosure relates to polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same.
|
|
WO/2012/038974 |
Provided is a process for the preparing l-phenyl-3-dimethylaminopropane derivatives of formula I, (The formula should be inserted here) and its pharmaceutically acceptable salts thereof via novel intermediates.
|
|
WO/2012/038459 |
The present invention relates to a process for preparing (meth)acrylic esters (F) of N,N‑substituted amino alcohols, by transesterifying N,N‑substituted amino alcohols (I) in which Y and Z are each independently C1-C20-alkyl, C3-C15-...
|
|
WO/2012/025941 |
The invention relates to improved process for the preparation of fesoterodine and its pharmaceutically acceptable salt, specifically fesoterodine fumarate of formula (1). The invention relates to solid state forms of a novel salt of feso...
|
|
WO/2012/016837 |
New ß-ketocarbonylquat compounds which contain one or more ß-ketocarbonyl groups of the general formula (I) and one or more quaternary ammonium groups, where the radicals R can be identical or different and are each an aliphatic hydroc...
|
|
WO/2012/005266 |
A liquid crystal aligning agent is characterised in having at least one polymer selected from a group comprising: polyamic acids obtained by reacting a diamine component containing a diamine compound represented by formula [1] with a tet...
|
|
WO/2012/001571 |
The object of the present invention is a new process for the synthesis of tapentadol, both as free base and in hydrochloride form, which comprises the step of alkylation of the ketone (VII) to yield the compound (VIII), as reported in Di...
|
|
WO/2011/154854 |
The present invention regards an improved and industrially advantageous process for the preparation of the 2-hyaroxy-4-phenyl-3,4-dihydro-2H-chromen-6-yl-methanol intermediates, also called "feso chromenyl" and (R)-2-[3-(diisopropylamino...
|
|
WO/2011/151120 |
The invention relates to novel quaternary ammonium compounds of the esterquat type, to a method for the production thereof, and to the use thereof in formulations.
|
|
WO/2011/151119 |
The invention relates to novel quaternary ammonium compounds of the esterquat type, to a method for the production thereof, and to the use thereof in formulations.
|
|
WO/2011/145019 |
The present invention relates to an improved process for the preparation of biologically active diphenylpropylamine derivatives. The present invention specifically relates to an improved fesoterodine of formula (I) and its pharmaceutical...
|
|
WO/2011/141932 |
Disclosed herein is an improved and efficient process for preparation of fesoterodine and its pharmaceutically acceptable salt. Disclosed also herein is novel intermediate of formula (III). Also disclosed are metal salts of formula (XII)...
|
|
WO/2011/141932 |
Disclosed herein is an improved and efficient process for preparation of fesoterodine and its pharmaceutically acceptable salt. Disclosed also herein is novel intermediate of formula (III). Also disclosed are metal salts of formula (XII)...
|
|
WO/2011/136368 |
Disclosed is a cationic lipid which is represented by formula (I) and makes it easier to introduce a nucleic acid into a cell. (In formula (I), R1 and R2 may be the same or different and each represents an alkenyl group or the like; X1 a...
|
|
WO/2011/120822 |
A fabric softener active composition, comprising at least 0 % by weight of a bis-(2-hydroxypropyl)-dimethylammonium 5 methylsulphate fatty acid ester having a molar ratio of fatty acid moieties to amine moieties of from 1.5 to 1.99, wher...
|
|
WO/2011/110556 |
A process is described for the preparation of intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)- 1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.
|
|
WO/2011/099810 |
The present invention relates to a method for preparing a cationic surfactant containing a compound of chemical formula 1, wherein the method comprises performing esterification on monomeric acid and triethanolamine or methyl dimethylami...
|
|
WO/2011/099810 |
The present invention relates to a method for preparing a cationic surfactant containing a compound of chemical formula 1, wherein the method comprises performing esterification on monomeric acid and triethanolamine or methyl dimethylami...
|
|
WO/2011/091197 |
The invention provides a method of continuously producing high quality quaternized N,N-dialkylaminoethyl (meth)acrylates (DMAEA-MCQ) that has a long shelf life and which is stable in water. The method involves placing starting marterials...
|
|
WO/2011/091197 |
The invention provides a method of continuously producing high quality quaternized N,N-dialkylaminoethyl (meth)acrylates (DMAEA-MCQ) that has a long shelf life and which is stable in water. The method involves placing starting marterials...
|
|
WO/2011/084719 |
Novel macromolecules for filtering contaminants from water and non-aqueous solutions. Molecules such as polyethyleneimine (PEI) may be functionalized, cross-linked, and/or quaternized to improve their binding capacity or selectivity with...
|
|
WO/2011/084719 |
Novel macromolecules for filtering contaminants from water and non-aqueous solutions. Molecules such as polyethyleneimine (PEI) may be functionalized, cross-linked, and/or quaternized to improve their binding capacity or selectivity with...
|
|
WO/2011/075210 |
A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound cor...
|
|
WO/2011/075210 |
A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound cor...
|
|
WO/2011/043549 |
The present invention relates to a fatty acid amino ester and to a skin-whitening composition comprising same. It is an aim of the present invention to provide a fatty acid amino ester which is not harmful to the human body and which has...
|
|
WO/2011/043549 |
The present invention relates to a fatty acid amino ester and to a skin-whitening composition comprising same. It is an aim of the present invention to provide a fatty acid amino ester which is not harmful to the human body and which has...
|
|
WO/2011/041529 |
The invention relates to tri-2-naphthylamines that can be useful in a variety of optical devices as hole-transport materials. For example, the tri-2-naphthylamines can be useful as hole-transport materials in organic light emitting diodes.
|
|
WO/2011/041529 |
The invention relates to tri-2-naphthylamines that can be useful in a variety of optical devices as hole-transport materials. For example, the tri-2-naphthylamines can be useful as hole-transport materials in organic light emitting diodes.
|
|
WO/2011/029005 |
Polymorphically pure crystalline forms of fesoterodine fumarate and fesoterodine base are described and characterized.
|
|
WO/2011/026144 |
Described herein are microneedle drug delivery systems comprising a pharmaceutical compositions comprising pharmaceutically active agents (e.g., cannabidiol and prodrugs of cannabidiol) and microneedle arrays suitable for local and syste...
|
|
WO/2011/022429 |
The present invention relates to a process for the preparation of alkyl esters of (S) 2-amino-5-cyclopropyl-4,4-difluoropentanoic acid, which are intermediates useful in the synthesis of (S)-N-(1-cyanocyclopropyl)-5-cyclopropyl-4,4-diflu...
|
|
WO/2011/022429 |
The present invention relates to a process for the preparation of alkyl esters of (S) 2-amino-5-cyclopropyl-4,4-difluoropentanoic acid, which are intermediates useful in the synthesis of (S)-N-(1-cyanocyclopropyl)-5-cyclopropyl-4,4-diflu...
|
|
WO/2011/012560 |
The invention pertains to high-molecular photoinitiator compounds comprising a photoactive moiety Q and an amine functionality, preferably a tertiary amino group, where the photoactive moiety Q is a benzoyl photoactive moiety.
|
|
WO/2011/012584 |
The invention relates to a process for obtaining 3,3- diphenylpropylamines of general formula (I), particularly Fesoterodine, as well as their enantiomers, solvates and salts, comprising a chemoselective reduction of the acid group again...
|
|
WO/2011/011352 |
An unsaturated quaternary ammonium salt is produced by a process that includes reacting methyl chloride in a first vessel with a stoichiometric excess of an unsaturated tertiary amine in the presence of water to form a reaction mixture t...
|
|
WO/2010/150816 |
Disclosed is a composition including at least one compound represented by formula (Z): A-L-{D1-(E)q-D2-(B)m-Z1-R}p (Z), where A is a linear or cyclic residue having a valence of p; L is a single bond or a divalent linking group; p is an ...
|
|
WO/2010/135092 |
A method and apparatus for preparing a N,N-dialkylaminoalkyl acrylate in a continuous transesterification reaction. The reaction involves adding alkyl acrylates such as methacrylate or ethacrylate to a reboiler mechanism and efficiently ...
|
|
WO/2010/135092 |
A method and apparatus for preparing a N,N-dialkylaminoalkyl acrylate in a continuous transesterification reaction. The reaction involves adding alkyl acrylates such as methacrylate or ethacrylate to a reboiler mechanism and efficiently ...
|
|
WO/2010/125092 |
3-Dialkylaminophenyl 2-alkoxycarbonylbenzoic compounds of formula (I), wherein R is selected from hydrogen, linear or branched (C1-C12)alkyl and (C5- C7)cycloalkyl; R1 and R2 are independently selected from hydrogen and linear or branche...
|
|
WO/2010/113600 |
The required properties for an existing reactive diluent are high refractive index, low viscosity, high diluting ability, high light transmissivity, and high UV curability. However, an acrylate ester derivative which satisfies these requ...
|
|
WO/2010/114291 |
The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention is able to reduce preparation costs by using low cost reagents on reaction and is able to be used...
|
|
WO/2010/114292 |
The present invention relates to an improved method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention allows reduction of production costs by reacting low cost reagents, improves yield and is ada...
|
|
WO/2010/114292 |
The present invention relates to an improved method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention allows reduction of production costs by reacting low cost reagents, improves yield and is ada...
|
|
WO/2010/114291 |
The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention is able to reduce preparation costs by using low cost reagents on reaction and is able to be used...
|
|
WO/2010/104082 |
A novel polyimide precursor or polyimide which can give a liquid-crystal alignment film having a low volume resistivity, a liquid-crystal alignment material comprising either of these polymers, a liquid-crystal alignment film, and a nove...
|
|
WO/2010/098023 |
Disclosed is a polymerizable monomer represented by formula (1) which is substituted by at least one group containing a polymerizable functional group. [In the formula, Ar1 and Ar4 to Ar6 independently represent a substituted or unsubsti...
|
|
WO/2010/083154 |
Heterofunctional segment-poly(ethylene glycol) polymers, conjugates of these molecules with therapeutic and/or imaging agents, and methods for their use are disclosed. The heterofunctional segment-poly(ethylene glycol) polymers are usefu...
|
|
WO/2010/083154 |
Heterofunctional segment-poly(ethylene glycol) polymers, conjugates of these molecules with therapeutic and/or imaging agents, and methods for their use are disclosed. The heterofunctional segment-poly(ethylene glycol) polymers are usefu...
|
|
WO/2010/067885 |
Disclosed is a softener composition containing a specific bis(polyalkoxyalkanol) type quaternary ammonium salt represented by general formula (I). [In the formula, R1 and R2 may be the same as or different from each other and independent...
|
